• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: EDWARDS LIFESCIENCES COMMANDER DELIVERY SYSTEM; AORTIC VALVE, PROSTHESIS, PERCUTANEOUSLY DELIVERED

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

EDWARDS LIFESCIENCES COMMANDER DELIVERY SYSTEM; AORTIC VALVE, PROSTHESIS, PERCUTANEOUSLY DELIVERED Back to Search Results
Model Number 9610TF23U
Device Problem Positioning Failure (1158)
Patient Problem Rupture (2208)
Event Date 08/31/2022
Event Type  Death  
Manufacturer Narrative
Investigation is still ongoing.
 
Event Description
As reported by an edwards (b)(6) affiliate, during a transfemoral tavr procedure with a sapien 3 ultra valve, there was resistance during insertion of the delivery system while advancing up the descending aorta and across the annulus.The team struggle to advance upon flex into the aortic arch and the position did not look right.They system was mid aortic arch, and started to back up upon push.It was decided to removed a little flex and continue to pushed on (no more than usual resistance confirmed).The patient developed severe discomfort at this point, and the operator tried to advance the system further.However, the system jumped.Per report, it is believed that the device caught on calcium at this point resulting in an rupture.Resuscitation was attempted, but the patient passed away.
 
Manufacturer Narrative
Correction to h6 based on additional information.The device was not returned to edwards lifesciences for evaluation, however, a device history record (dhr) review was done, and did not reveal any manufacturing nonconformance issues that would have contributed to the event.A lot history review was performed and revealed no other complaints relating to the reported event were identified.The instructions for use/training manuals were reviewed for guidance/instruction involving the esheath and delivery system usage.Based on the review of the ifu/training manuals, no deficiencies were identified.A review of edwards lifesciences risk management documentation was performed for this case.The reported event is an anticipated risk of the transcatheter heart valve procedure, additional assessment of the failure mode is not required at this time.The complaint for unable to track system through anatomy was unable to be confirmed due to unavailability of the complaint device and/or applicable imagery.As the device was not returned for evaluation, engineering was unable to perform any visual, functional, or dimensional analysis.Therefore, a manufacturing non-conformance could not be determined.As reported, 'upon advancing the commander system, it seemed to struggle to advance upon flex into the aortic arch and position did not look right.System only got to mid aortic arch and started to back up on itself upon push.Lead consultant then removed a little flex and pushed on (confirmed did not feel a lot of resistance, no more than usual).Patient started to have severe discomfort in the back at this point.Doctor tried to advance the system on.System, then, jumped and it is now believed the calcium it caught on came with system at this point resulting in a rupture.' presence of calcification in the aorta can cause interaction between the advancing delivery system with thv and calcified nodules present, contributing to the reported tracking difficulty and possibly damaging the surround tissue and resulting in the reported aortic rupture.However, definitive root cause was unable to be determined at this time.Available information suggests patient (calcification) and/or procedural factors (excessive manipulation) contributed to the reported event.Complaint histories for all reported events are reviewed against trending control limits on a monthly basis, and any excursions above the control limits are assessed and documented as part of this monthly review.No corrective or preventative actions are required.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
COMMANDER DELIVERY SYSTEM
Type of Device
AORTIC VALVE, PROSTHESIS, PERCUTANEOUSLY DELIVERED
Manufacturer (Section D)
EDWARDS LIFESCIENCES
1 edwards way
irvne CA 92614
Manufacturer (Section G)
EDWARDS LIFESCIENCES
1 edwards way
irvine CA 92614
Manufacturer Contact
renee van dorne
1 edwards way
irvine, CA 92614
9492506385
MDR Report Key15506425
MDR Text Key300861187
Report Number2015691-2022-08151
Device Sequence Number1
Product Code NPT
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P140031
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,User Facility
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 10/28/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date05/08/2024
Device Model Number9610TF23U
Device Lot Number64367920
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Initial Date Manufacturer Received 08/31/2022
Initial Date FDA Received09/29/2022
Supplement Dates Manufacturer Received10/26/2022
Supplement Dates FDA Received10/28/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured05/09/2022
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Death; Required Intervention;
Patient Age84 YR
Patient SexFemale
-
-